Iida, Hiroatsu http://orcid.org/0000-0002-3238-9087
Imada, Kazunori
Ueda, Yasunori
Kubo, Kohmei
Yokota, Akira
Ito, Yoshikazu
Kiguchi, Toru
Hata, Tomoko
Nawa, Yuichiro
Ikezoe, Takayuki
Uchida, Toshiki
Morita, Yasuyoshi
Kawashima, Ichiro
Chiba, Masahiro
Morimoto, Kensaku
Hirooka, Shihomi
Miyazaki, Yasushi
Ohno, Ryuzo
Naoe, Tomoki
Usuki, Kensuke
Ando, Kiyoshi
Yamauchi, Takahiro
Kuroda, Junya
Ishikawa, Takayuki
Iwasaki, Hiromi
Suzuki, Takahiro
Kitamura, Kenichi
Uchiyama, Hitoji
Ichikawa, Satoshi
Imajo, Kenji
Hanamoto, Hitoshi
Miyawaki, Shuichi
Usui, Noriko
Asou, Norio
Hirakawa, Akihiro
Kuriyama, Kazutaka
Muta, Masakazu
Taniwaki, Masafumi
Takahashi, Yukari
Dohi, Atsushi
Nakanishi, Yoko
Nakaoka, Ryuhei
,
Article History
Received: 17 November 2021
Revised: 3 February 2022
Accepted: 6 February 2022
First Online: 24 February 2022
Declarations
:
: Azacitidine was provided by Nippon Shinyaku Co., Ltd. IH reports all support for the present manuscript from Nippon Shinyaku Co., Ltd., grants from Chugai Pharmaceutical Co., Ltd., and payment from Astellas Pharma Inc., Kyowa Kirin Co., Ltd., Janssen Pharmaceutical K.K., Novartis Pharma K.K., and Abbvie Inc. KI reports honoraria from Nippon Shinyaku Co., Ltd. AY reports payments from Nippon Shinyaku Co., Ltd. TK reports grants from Nippon Shinyaku Co., Ltd. TU reports honoraria from Pfizer Japan Inc. YM reports research funding of this study from Nippon Shinyaku Co., Ltd., grants from Sumitomo Dainippon Pharma Co., Ltd., and payments from Astellas Pharma Inc., Sumitomo Dainippon Pharma Co., Ltd., Chugai Pharmaceutical Co., Ltd, Kyowa Kirin Co., Ltd., Abbvie Inc., Novartis Pharma K.K., Bristol-Myers-Squibb K.K., Pfizer Japan Inc., Janssen Pharmaceutical K.K., Eisai Co., Ltd., Daiichi Sankyo Company Limited., Takeda Pharmaceutical Company Limited., Sanofi K.K. and Nippon Shinyaku Co., Ltd. TN reports grants from Astellas Pharma Inc., Daiichi Sankyo Company Limited. And FUJIFILM Corporation., payments from Astellas Pharma Inc., Bristol-Myers-Squibb K.K., Otsuka Pharmaceutical Co., Ltd., Sysmex Corporation and Nippon Shinyaku Co., Ltd. RO reports consulting fees from Nippon Shinyaku Co., Ltd.